1A

The State Of Care For Perinatal And Postpartum Depression

08.30.2021 - By NPRPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Nearly one in seven people who give birth experience postpartum depression.

Right now, there's only one PPD medication, called brexanolone, currently approved by the FDA.

While it's known to be extremely effective, access is very limited.

But a revolution in treating perinatal and postpartum depression may be underway.

We talk with experts about the current landscape of treatment for perinatal and postpartum depression and what FDA approval of a new medication, zuranolone could mean.

Want to support 1A? Give to your local public radio station and subscribe to this podcast. Have questions? Find us on Twitter @1A.

More episodes from 1A